Search the Newsreel

StepStone Group (STEP) On Mixed Earnings And What That Means For Valuation

StepStone Group (STEP) reported mixed Q1 2026 results with increased revenue but a wider net loss, leading to a reassessment of its stock valuation. The company's price-to-sales (P/S) ratio of 1.9x suggests it is overvalued compared to an estimated fair P/S of 0.9x, despite …

How Strong Q2 Results And New Castlelake Loan Pact At Upstart (UPST) Has Changed Its Investment Story

UPST: Record Q2 profits and strategic focus on core lending signal a new phase of AI-driven growth

Upstart Holdings, Inc. (UPST) reported record Q2 profits, driven by strong performance in core personal loans and improved margins in secured products. The company is undergoing a leadership transition and renewed focus on contribution profit, addressing investor concerns about capital efficiency and operating leverage. …

Transcript : Upstart Holdings, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-11-2026 11

Upstream Bio (UPB) Earnings Date and Reports 2026 $UPB

Upstream Bio (UPB) announced its Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.73, beating analyst estimates by $0.01. The company also exceeded revenue expectations with $0.77 million against an estimated $0.56 million. Despite beating estimates, Upstream Bio's earnings are projected …

Upstream Bio (NASDAQ:UPB) Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Upstream Bio (NASDAQ:UPB) announced its quarterly earnings, reporting an adjusted loss of $0.73 per share, surpassing analyst expectations of a $0.78 loss by $0.05. The company also exceeded revenue forecasts, reaching $0.77 million against an expected $0.43 million. Despite beating estimates, Upstream Bio remains …

Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates

Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP

Upstream Bio has released a corporate presentation detailing its plans for verekitug, a TSLP receptor antagonist, including a mid-2026 FDA meeting and Phase 3 trials in severe asthma and CRSwNP targeting Q1 2027. The company's pipeline shows promising Phase 2 data for verekitug in …

Form 8K Upstream Bio Inc For: 11 August By Investing.com

This article announces that Upstream Bio Inc. has filed a Form 8K on August 11, with its stock symbol UPB showing a 2.22% increase. The content provided is primarily a placeholder for this financial filing, with minimal specific details about the 8K's contents. It …

Upstream Bio, Inc. 2Q 2026: Revenue $0.8M, EPS $(0.73) — 10-Q Summary

Upstream Bio, Inc. reported its second-quarter 2026 results, showing revenue of $0.8M and a net loss of $39.7M, resulting in a diluted EPS of $(0.73), which is largely consistent with the previous year. The company highlighted clinical progress for Verekitug in severe asthma and …

Upstream Bio (UPB) deepens R&D spend but ends quarter with $261M cash

Upstream Bio (NASDAQ: UPB) reports Q2 2026 loss and advances Phase 3 plans

Upstream Bio (NASDAQ: UPB) reported a Q2 2026 net loss of $39.7 million, similar to the previous year, with cash reserves of $261.3 million expected to fund operations through 2027. The company is advancing its lead asset, verekitug, towards Phase 3 trials for severe …

Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress

Upstream Bio announced its second-quarter 2026 financial results, highlighting significant progress in developing verekitug for severe inflammatory respiratory diseases. The company is on track to initiate Phase 3 trials for severe asthma and CRSwNP in Q1 2027 and has completed enrollment for its Phase …

252% Stock Return vs 57% Profit Growth: What Drives Kapston Services Ltd’s Multibagger Rally?

STEP Q2 Deep Dive: Private Wealth Momentum and Strategic M&A Shape Outlook

STEP Q2 Deep Dive: Private Wealth Momentum and Strategic M&A Shape Outlook Private markets investment firm StepStone Group (NASDAQ:STEP) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 26.6% year on year to $300.6 million. Its non-GAAP profit of $0.48 per share …

Kapston Services consolidated net profit rises 38.50% in the June 2026 quarter

StepStone Stock Falls After Missing Quarterly Earnings Estimates Despite Raising Dividend Payout

Is Upstart Holdings (UPST) Cheap On Stronger Earnings And A $4b Castlelake Deal?

UPST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds

Bronstein, Gewirtz and Grossman, LLC has filed a class action lawsuit against Upstart Holdings, Inc. (NASDAQ:UPST) and some of its officers. The lawsuit alleges that Upstart made false and misleading statements regarding its AI underwriting model's accuracy and impact on revenue. Investors who purchased …

Kapston Services Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Why Upstart Stock Plunged 23% in July

Key Points High interest rates and concerns about software-as-a-service stocks in the agentic AI era have weighed on Upstart stock. Upstart delivered solid performance in the second quarter, with a 42% year-over-year increase in revenue and positive net income. Management says it has an …

CEPL PE Ratio & Valuation, Is CEPL Overvalued

Capstone Energy+ Inc (CEPL) is currently in the "Fair" valuation zone, with a forward PE ratio of 41.67, closely aligning with its five-year average. Its fair price is estimated to be between $8.49 and $8.84 based on relative valuation. However, CEPL's P/S ratio of …

StepStone Group (STEP) Stock Drops As SPW Funding Risk Clouds Fee Growth

StepStone Group's stock dropped almost 8% due to concerns over Private Wealth (SPW) funding risks, despite strong fee-related earnings. While fee revenue and adjusted net income improved, the company reported a widened GAAP net loss of US$116 million, largely due to accounting for the …

CEPL Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for Capstone Energy+ Inc (CEPL) as of August 9, 2026. It highlights a "Neutral" overall technical consensus, with specific indicators like RSI and MACD also suggesting a neutral stance. The analysis notes that CEPL …

Upstart Holdings (UPST) Is Up 5.8% After $4 Billion Loan Pact And Conditional Bank Approval

Upstart Holdings (UPST) saw its stock rise by 5.8% following two significant announcements: a new $4 billion forward-flow agreement with Castlelake-managed funds for consumer loan purchases, and conditional approval from the Office of the Comptroller of the Currency to establish a nationwide, AI-driven digital …

StepStone Group (NASDAQ:STEP) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Upstream Bio Inc (UPB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Upstream Bio Inc (UPB) has an earnings forecast score of 7.78, ranking 268th in the Biotechnology & Medical Research industry. Analysts project an average price target of $43.00, with a strong "Buy" rating based on 9 analysts. The company's expected revenue for the next …

StepStone Group Inc. 2027 Q1 - Results - Earnings Call Presentation (NASDAQ:STEP) 2026-08-07

StepStone Group (STEP) Releases Q1 2027 Earnings: Revenue Tops Expectations but Loss Widens

StepStone Group (STEP) Is Up 15.4% After Revenue Surges But Loss Widens – Has The Bull Case Changed?

StepStone Group Inc. reported first-quarter 2027 results on August 6, 2026, with revenue rising to US$378.89 million while net loss widened to US$115.82 million compared with the same period a year earlier. Despite strong top-line growth and some operating metrics exceeding expectations, the company …

Capstone Holding Corp (CAPS) Stock News Today

This article provides current stock information for Capstone Holding Corp (CAPS), including its trading price, daily change, and market capitalization. It highlights that more news, earnings reports, and analyst ratings for CAPS are anticipated soon. The page serves as a hub for investors to …

Press Release: Capstone to Report Second Quarter 2026 Financial Results on August 12

Capstone will release its financial results for the second quarter of fiscal year 2026 on Wednesday, August 12, 2026. This will be followed by a conference call and webcast hosted by CEO Darren Jamison and CFO Frederick H. Weisenburger to discuss the results and …

StepStone Group reports Q1 FY2027: Total revenues $378.9M, ANI $60.3M, declares $0.33 quarterly dividend

StepStone Group announced its Q1 FY2027 results, reporting total GAAP revenues of $378.9 million and an adjusted net income (ANI) of $60.3 million. The company declared a quarterly cash dividend of $0.33 per Class A share, payable on September 15, 2026. Key business highlights …

CAPS Q2'26 Earnings: revenue estimate is 20.39M USD

Capstone Holding Corp. (CAPS) is expected to announce its Q2'26 earnings on August 13, with an estimated revenue of $20.39 million and an EPS of $0.12. The article provides a historical comparison of reported and estimated revenue and EPS figures for recent quarters, including …

Capstone Holding Corp (CAPS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Capstone Holding Corp (CAPS) has an earnings forecast score of 8.00, placing it 3rd in the Construction Materials industry. Analysts have set an average price target of $6.00 for CAPS, with a consensus "Buy" rating based on one analyst. The company's expected revenue for …

Compared to Estimates, StepStone Group (STEP) Q1 Earnings: A Look at Key Metrics